Back
Alnylam Pharmaceuticals Vs. RH Industry Stock Comparison
Sell
45
ALNY
Alnylam Pharmaceuticals
Last Price:
$253.59
Seasonality Move:
2.85%
Sell
27
RH
RH
Last Price:
$234.12
Seasonality Move:
36.68%
Sell
45
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $253.44. The Score for ALNY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
-
RH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $253.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RH Stock Price Chart
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.9 | Sell |
| Relative Strength Index (14 RSI): | 53.41 | Buy |
| Chaikin Money Flow: | 670757 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (240.6 - 259.34) | Buy |
| Bollinger Bands (100): | (240.11 - 273.11) | Sell |
RH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -43.73 | Sell |
| Relative Strength Index (14 RSI): | 26.33 | Sell |
| Chaikin Money Flow: | 307531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (247.84 - 374.14) | Sell |
| Bollinger Bands (100): | (307.39 - 419.45) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 245.01 | Buy |
| 20-day SMA: | 245.95 | Buy |
| 50-day SMA: | 255.01 | Sell |
| 200-day SMA: | 249.59 | Buy |
| 8-day EMA: | 247.04 | Buy |
| 20-day EMA: | 248.72 | Buy |
| 50-day EMA: | 252.72 | Buy |
| 200-day EMA: | 242.45 | Buy |
RH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 231.61 | Sell |
| 20-day SMA: | 292.56 | Sell |
| 50-day SMA: | 364.96 | Sell |
| 200-day SMA: | 320.34 | Sell |
| 8-day EMA: | 239.26 | Sell |
| 20-day EMA: | 282.08 | Sell |
| 50-day EMA: | 332.75 | Sell |
| 200-day EMA: | 331.26 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, an increase next quarter of $1.48 per share, an increase this year of $0.76 per share, and an increase next year of $2.81 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.67 per share, a decrease next quarter of $0.77 per share, a decrease this year of $2.06 per share, and an increase next year of $7.27 per share.
Alnylam Pharmaceuticals Technical Analysis
| Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RH Technical Analysis
| Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||